Pharmaceutical Biotechnology (Record no. 2277)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01354 a2200301 4500 |
| 001 - CONTROL NUMBER | |
| control field | 1420044370 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250317100410.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 250312042007xx 227 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781420044379 |
| 037 ## - SOURCE OF ACQUISITION | |
| Source of stock number/acquisition | Taylor & Francis |
| Terms of availability | GBP 82.99 |
| Form of issue | BB |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | 01 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PS |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | TDCW |
| Source | thema |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | PS |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | TDCW |
| Source | bic |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | MED071000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | SCI013000 |
| Source | bisac |
| 072 7# - SUBJECT CATEGORY CODE | |
| Subject category code | 615.19 |
| Source | bisac |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Daan J. A. Crommelin |
| 245 10 - TITLE STATEMENT | |
| Title | Pharmaceutical Biotechnology |
| Remainder of title | Fundamentals and Applications, Third Edition |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 3 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | CRC Press |
| Date of publication, distribution, etc. | 20071030 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 512 p |
| 520 ## - SUMMARY, ETC. | |
| Expansion of summary note | Completely revised text that reflects to emergent trends and cutting-edge advances in pharmaceutical biotechnology, this Third Edition provides a well-balanced framework for understanding every major aspect of pharmaceutical biotechnology, including drug development, production, dosage forms, administration, and therapeutic developments. New chapters cover evolving areas regarding biopharmaceuticals, including oligonucleotides, siRNA and various monoclonal antibodies, immunogenicity, gene therapy, and the regulatory issues factoring into the biopharmaceutical approval process |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Robert D. Sindelar |
| Relationship | B01 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bernd Meibohm |
| Relationship | B01 |
No items available.